Herbalife Posts Fourth Straight Quarter of Sales Growth Amid FX Headwinds
Event summary
- Herbalife reported $1.3 billion in Q2 2026 net sales, up 5.4% YoY (5.8% constant currency), marking its fourth consecutive quarter of topline expansion.
- Adjusted EBITDA exceeded guidance at $166.6 million ($174.4 million constant currency) despite a $94.6 million loss on debt extinguishment.
- Launched Bioniq GO personalized nutrition product in Europe and the U.S., alongside new Life I/O products Helio and Activate Energy.
- CFO John DeSimone to retire; Scott Schaefer announced as successor effective January 2027.
The big picture
Herbalife's consistent sales growth reflects its strategic focus on personalized nutrition products and digital platform enhancements. The company's ability to navigate FX pressures while expanding in key markets like Europe and Asia will be crucial for maintaining momentum. The leadership transition adds an element of uncertainty as the new CFO takes over amid a period of product innovation and market expansion.
What we're watching
- FX Volatility Impact
- Whether Herbalife can sustain growth momentum amid persistent foreign exchange headwinds affecting reported results.
- Product Innovation Pace
- How the rollout of Bioniq GO and Life I/O products will influence customer acquisition and retention in competitive markets.
- Leadership Transition Risk
- The potential impact of CFO John DeSimone's retirement on financial strategy execution during a critical growth phase.